Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Astrocytoma 8Glioblastoma 5Prostatic Neoplasms 4Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 3Recurrence 2Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Pituitary Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Phantoms, Imaging 6Cyclophosphamide 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Topotecan 4Etoposide 4Biopsy 4palbociclib 3Vincristine 3Methotrexate 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2Radiotherapy 2Nivolumab 2LY3023414 2Carboplatin 2selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rhabdoid Tumor × antineoplaston AS 2-1 × Clear all
NCT00003469 2017-08-24

Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

Burzynski Research Institute

Phase 2 Terminated
4 enrolled 6 charts

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡